Merck & Co., Inc (NYSE: MRK) Gains A Upper Hand Against Pfizer Inc (NYSE: PFE) In Timing Of next-gen Pneumococcal Vaccines For Kids

Pfizer Inc (NYSE: PFE) and Merck & Co., Inc (NYSE: MRK) are in race to expedite the launch of next-gen pneumococcal vaccines by the end of this year. However, Merck gains an upper hand for kids’ vaccines. Timing advantage In a communiqué, Merck said its V114 completed the efficacy and safety thresholds in two phase 3 […]

NuvaRing, Zilmax Add Further Trouble To Merck & Co., Inc. (NYSE:MRK)’s Financial Slide

Boston, MA 03/18/2014 (wallstreetpr) – Even as several new pharmacy companies are reporting new inventions that may boost their image as well as revenue biggies like Merck & Co., Inc. (NYSE:MRK) are clearly struggling to retain their hold. As per the Q4 results of FY 13, MRK’s revenue slid to $11.30 billion for the quarter which […]

$688 Million “ENHANCE” Settlement Could Pull Merck’s Q4, 2012 EPS By 16 Cents

Boston, MA 02/14/2013 (wallstreetpr) – The renowned healthcare solution provider, Merck & Co Inc., (NYSE: MRK) have settled two US investor-lawsuits for $688 million, it declared yesterday. The company was sued by several of its institutional investors (pension funds) in a class action lawsuit over knowingly withholding information about the potential of failure in another […]